Silk Road Medical is a California-based company that focuses on reducing the risk of stroke caused by carotid artery disease. They have developed a new approach called TransCarotid Artery Revascularization (TCAR), which combines surgical principles of neuroprotection with minimally invasive endovascular techniques. TCAR has been clinically proven to treat blockages in the carotid artery and reduce the upfront risks associated with traditional carotid endarterectomy procedures. Silk Road Medical's portfolio of products, including the ENROUTE® Transcarotid Neuroprotection and Stent System, is specifically designed for high surgical risk patients in need of carotid intervention. By collaborating with vascular surgeons and continuously improving their technology, Silk Road Medical aims to improve the lives of people with arterial disease.